From: Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis
Population | Sample size | Dominant comparison | Recessive comparison | Additive comparison | Allele comparison | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P value | OR (95%CI) | I2 statistic | P value | OR (95%CI) | I2 statistic | P value | OR (95%CI) | I2 statistic | P value | OR (95%CI) | I2 statistic | ||
rs1501299 G/T | GG vs. GT + TT | TT vs. GG + GT | GT vs. GG + TT | G vs. T | |||||||||
Overall | 2602/3773 | 0.10 | 1.17 (0.97–1.42) | 52% | 0.02 | 0.77 (0.62–0.95) | 46% | 0.52 | 0.94 (0.76–1.15) | 58% | 0.001 | 1.15 (1.06–1.26) | 43% |
Caucasian | 685/545 | 0.007 | 1.40 (1.09–1.79) | 42% | 0.79 | 0.94 (0.62–1.45) | 0% | 0.01 | 0.73 (0.58–0.93) | 48% | 0.03 | 1.22 (1.02–1.46) | 22% |
East Asian | 509/568 | 0.006 | 1.41 (1.10–1.81) | 37% | 0.0003 | 0.48 (0.32–0.71) | 0% | 0.76 | 0.96 (0.75–1.23) | 17% | 0.0001 | 1.44 (1.20–1.73) | 2% |
West Asian | 803/688 | 0.19 | 0.87 (0.71–1.07) | 4% | 0.88 | 0.95 (0.47–1.89) | 70% | 0.30 | 1.19 (0.85–1.68) | 62% | 0.52 | 0.95 (0.81–1.11) | 31% |
rs2241766 T/G | TT vs. TG + GG | GG vs. TT + TG | TG vs. TT + GG | T vs. G | |||||||||
Overall | 2358/4034 | 0.63 | 1.03 (0.91–1.18) | 46% | 0.54 | 1.10 (0.81–1.50) | 41% | 0.44 | 0.95 (0.83–1.09) | 44% | 1.00 | 1.00 (0.84–1.19) | 54% |
Caucasian | 966/1280 | 0.32 | 0.89 (0.70–1.12) | 22% | 0.04 | 1.93 (1.05–3.56) | 26% | 0.84 | 1.03 (0.80–1.31) | 6% | 0.11 | 0.84 (0.68–1.04) | 46% |
East Asian | 509/568 | 0.74 | 0.93 (0.62–1.40) | 61% | 0.86 | 1.10 (0.40–3.02) | 59% | 0.54 | 1.17 (0.71–1.93) | 73% | 0.95 | 0.99 (0.73–1.35) | 58% |
West Asian | 803/686 | 0.31 | 1.22 (0.83–1.80) | 65% | 0.56 | 0.85 (0.49–1.47) | 8% | 0.31 | 0.83 (0.59–1.18) | 53% | 0.32 | 1.19 (0.84–1.69) | 67% |